Idiopathic pulmonary fibrosis
| Autor: | Jason S. Zolak, Joao A. de Andrade |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
medicine.medical_specialty
Immunology Food and drug administration 03 medical and health sciences Idiopathic pulmonary fibrosis 0302 clinical medicine Quality of life Parenchyma medicine Immunology and Allergy Humans Intensive care medicine Lung function 030304 developmental biology 0303 health sciences business.industry Clinical course respiratory system medicine.disease Idiopathic Pulmonary Fibrosis respiratory tract diseases 3. Good health Surgery Clinical trial 030228 respiratory system Lung disease business |
| Zdroj: | Immunology and allergy clinics of North America. 32(4) |
| ISSN: | 1557-8607 |
| Popis: | Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown cause characterized by progressive scarring of the lung parenchyma and relentless loss of lung function. The diagnosis depends on close collaboration between clinicians, radiologists, and pathologists. No therapies approved by the Food and Drug Administration are available for IPF, and an analysis of completed clinical trials has demonstrated that the clinical course of IPF is largely unpredictable. Until therapies that improve survival become available, measures to preserve function and quality of life should be considered, and gastroesophageal reflux should be treated aggressively. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|